• Metadoro
  • Products
  • News and analysis

News and analysis

Check market insights shared by our community members
12.05.2022
Perspective ETFs in the ESG energy segment: Invesco Global Clean Energy Portfolio ETF

This ETF invests in green energy ventures. The pandemic led to a 300% increase of its share price. But since the beginning of 2022 they have lost 30%, twice as much as the S&P 500 SPY ETF. The net capital which has outflown from the Fund has reached $31.5 billion over the last 12 months, while the major outflow was recorded in December 2021. However, its shares are still seen to be overbought as P/E multiplier is at 24 that is well above the average of 20 for the EFT’s that are linked to the S&P 500, while the dividend yields are above PBD’s numbers.

Inflation in the United States is rising negatively affecting all shares with a high P/E ratio. So, we may expect a further decline of the PBD share price and other similar assets that cannot be protected from rising risks. Traditional energies are looking more attractive on this background and could be a perfect hedge asset amidst geopolitical uncertainties. 

26.11.2024
Meta Could Score 18% in the Next Few Months

Meta Platforms (META), the parent company of Facebook and Instagram, has been trading sideways within the $550-600 range since late September, underperforming the tech-heavy Nasdaq 100 index, which has gained 6.0% during the same period.

While META shares remain within an ascending channel, they are currently resting at the support of the uptrend. Historically, each time the stock reached this level, it rebounded upwards by 15-18%. Consequently, the share price is likely to rise to $650-670 over the coming months. I plan to open a long trade at $550-570, targeting a potential upside of $185. A stop-loss could be placed below recent lows at $480.

12.04.2024
CarMax Is More Committed to Innovations But Market Conditions Make It Sinking

CarMax (KMX) quarterly report came out on April 11, vividly displaying why any immediate investment into the used car market still sounds like not a good idea. The stock quickly lost ground, wasting a double-digit number of percentage points as a response to its net income drop to $0.32 per share against $0.44 cents per share a year ago, also compared to much stronger $0.52, $0.75 and $1.44 per share in the previous three quarters. Analyst polls estimated a net income per share at about $0.50, which would be 56% better than the reality.

This almost looks like a financial fiasco in the company's efforts to withstand slowing demand in the segment. CarMax Q4 2023 revenue decreased by 1.7% to $5.6 billion, slightly below consensus expectations of $5.8 billion, indicating the lack of gross marginality of the business. This happened even though the total supply of unsold used vehicles on dealer lots grew by 9% YoY to 2.27 million units in March, according to Cox Automotive data. CarMax CEOs delayed their own goal of selling over 2 million units annually, when measuring combined retail and wholesale actions, to between 2026 and 2030, from its prior target of 2026.

A "higher-for-longer" Fed fund rates is demonstrably bad for car sales volumes, be it new generation Tesla cars or just pre-owned vehicles, while operating costs for warehouses are growing. Besides, easing some semiconductor constraints in North America may help marginally improving orders for new cars, leaving used-car sales under the same pressure. Meanwhile, the entrance of Asia players offered significant discounts. Therefore, North American and European operators of the used car market need to sell many great cars at cheaper prices. CarMax already posted its official warning of a potential "hit to profit-sharing revenue" due to inflationary impact to its partners, before last Christmas. "While affordability of used cars remains the challenge for consumers, pricing improved during the quarter," Enrique Mayor-Mora, executive vice president and CFO admitted.

It was only a smaller division of CarMax Auto Finance, which managed to get a 19% better income due to "a lower provision for loan losses" and an increase in average managed receivables. Yet, this was rather news from the side business, which was clearly not enough to be optimistic. The company added that it is now focused on enhancing its omni-channel experience and leveraging data science and automation. Carmax said it delivered "strong retail and wholesale" graphic processors, which helped to increase "used saleable inventory units" more than 10%, but used total inventory units was unchanged despite innovations. The company seeks to achieve efficiency improvements in its core operations, believing that they "are well-positioned to drive growth as the market turns", according to Enrique Mayor-Mora. This may be useful to strengthen competitiveness in better times for the segment. Yet, the current challenges are too heavy to be ignored by market crowds.

15.09.2022
Safe Haven Assets for Long-Term Investments: Broadcom

Broadcom is an American semiconductor and infrastructure software development company. Soon it is expected to close a merger deal with VMware, a cloud computing and visualization company, that will open new cross-sales opportunities for Broadcom to boost its revenues. Broadcom stocks are now 25% off their peak values.

According to the Q3 FY 2022 financial report that ended July 31, consolidated revenues grew by 25% year-over-year to $8.46 billion, and EPS went up by 40% to $9.73 per share. The semiconductors segment, that added 32% year-over-year, was the primary driver for the company’s profit. The company’s free cash flows (FCF) topped $4.3 billion, allowing it to spend $1.7 billion on dividends and 1.5 billion on the shares repurchase program. The company is planning to continue spending at least 50% of FCF on dividends that added 43% every year on average since 2016. 

According to the Q4 FY 2022 forward guidance, the company is expecting its revenues to go up by 20% year-over-year to $8.9 billion and for EDITDA to go up by 25% to $5.6 billion. Broadcom has great experience in expanding its product portfolio by M&A operations, and apparently it will continue on this way. The company is also expected to benefit greatly from the $52.7 billion CHIPS bill in the United States.


11.08.2022
Perspective Peers of Ethereum: Avalanche

Avalanche is ranked by Coinmarketcap at the 12th position by market cap with $7.8 billion, which is 4% less than Ethereum’s market cap. AVAX prices dropped by 82% of its peak values, allowing investors to buy it at early 2021 prices. Avalanche’s infrastructure consists of three logically isolated networks, each of these with their own processing, validators, and own set of rules.

This platform is often compared to the existing internet web infrastructure with core connection protocols like HTTP, surrounded by a huge number of networks to their apps. Avalanche allow for the creation of public and private systems as a blockchain or DAG (Directed Acyclic Graph) and for the use of different virtual machines for apps, including EVM engine (Ethereum Virtual Machine) that allows Enthereum network programs to be developed.

Avalanche includes C-chain to create smart contracts that are processed on an advanced EVM engine, P-Chain that coordinates validators that process transactions and also allows for the creation and management of new subnetworks, and X-Chain which is a directed acyclic graph regulating issuance and trade of cryptoassets. DAG systems record new transactions on top of the old ones, allowing for processing speed to be increased and for capacity substantially. It is quite different to other blockchains, where transactions are compiled in blocks in order to be processed.

The advantage of Avalanche is that it provides anyone with the opportunity to create his or her own isolated blockchain with its own set of parameters, including access to apps and the programming language with which it will work. Every subnetwork can process around 4,500 transactions per second compared to 14 processed by the Ethereum network.

Microsoft May Go to December 2023 Dips

The Windows OS developer joined the widening group of tech companies that partially lost their market values this month. In almost every case, a price drop happened despite solid, and even better-than-expected quarterly numbers.

This all started with Google-parent Alphabet's decline last week, after only one conventionally weak spot has been discovered in its YouTube segment, while other parts of its business performed strongly, though didn't break any new records. In a very similar way, late yesterday evening Microsoft posted its earnings per share (EPS) of $2.95 on sales of $64.7 billion instead of EPS of $2.94 per share on sales of $64.38 billion in consensus estimates. Money-generation indications showed only an inch higher compared with the recent two quarters, despite 4.5% growth in revenue quarter-by-quarter and nearly 15% jump in quarterly revenue year-on-year. However, this is not enough reason for an immediate continuation of the price rally, so that Microsoft share price went down to test the levels well below $400, losing more than 6.5% already within the first hours of the extended trading on Wall Street.

A nominal excuse for Microsoft share price sinking was attributed to its Azure cloud business growth pace at 29% to slightly miss overheated average analyst pool bets on 30.2%, probably made out of the blue beforehand. Anyway, a slowdown is detected compared to 31% YoY at the end of the previous quarter. Now, searching for a new bottom in one of the three most capitalized companies in the world would become another challenge for the nervous market community during the hot corporate reports' season. A price discount against the fresh all-time high at $468.35 (set on July 5) reaches a large amount of about $75 per share, or 16%, when moving within current price ranges.

By the way, AI (artificial intelligence) related pace accounted for about 8% of Azure's numbers, up from 7% in Q1 to prove higher AI demand. Good for other giants' business on the AI basis, but no obstacle for some further price adjustment in both Microsoft stock and broader markets. Capital spending jumped to $19 billion from $14 billion in Q1 2024 and $10.7 billion in Q2 2023. Revenue in productivity and business processes rose 11% to $20.3 billion to lay the backbone for a more profitable future. However, the current price move may lead to a test of lower dips between $360 and $375, last seen in December 2023, according to our estimates. These technical levels may evoke a stronger buying activity.

5088
B
Buying More of Amazon

My personal feeling is that Amazon's quarterly report may have the ability to surprise investors from August 1st. During a recent background of massive correction moves in techs, shares of Amazon lost about 7.5% from 8th to 30th of July, compared to the e-commerce bellwether's peaking price above $200. This represented not such a big discount compared to many other components of the Nasdaq Composite index, pointing that the crowd wants to believe in Amazon's strength. Meanwhile, the impact of Microsoft's drop in the after-hours trading yesterday quickly increased this gap in Amazon price to 12% from all-time highs, which makes shares of Amazon much more attractive.

Analysts' consensus projections for a more than 10% surplus in Q2 sales to approach $150 billion are here, also betting for an EPS at least an inch above the psychological threshold of $1 per share, as it was last Christmas quarter's record achievement for the time being. However, could you imagine what would happen with a price if actual numbers come out far beyond consensus estimates? First, accelerating demand on cloud computing is a factor to drive Amazon Web Services (AWS) marginality up to the skies. The help of generative AI tailwinds is real. If so, forget about Amazon's core business, even though it is seemingly climbing to new highs as well. The retail platform and advertising income may benefit much from Amazon's faster deliveries, which may give more conversion, despite all those struggling low-end consumers. There was a big crowd of new loyalty program sign-ups on Prime Day. It generated $14 billion in sales in the US to mark nearly 11% of gains YoY, Adobe Analytics figured. This may boost overall record sales well above consensus ideas. I anticipate the sales number above $155 billion and EPS of $1.10 or even better.

That's why I decided to buy more Amazon shares, even without waiting for the official quarterly release. A break through $190 may give an extra boost to the stock's price immediately, but I don't want to buy above $200, when it currently trades between $175 and $180. Well, if something goes wrong, Amazon will come back soon. Yet, in my baseline scenario, the stock price would soar by double-digits, in after-hours this Thursday's night. Citigroup now has its target price for Amazon at $245 (!) per share, projecting a 17.5% surplus in AWS and operating income of $13.88 billion. This is surely not the main argument for my mind, but this certainly gives me extra power to stay positive on Amazon.

4732
A Chance to Add More to Stakes in Merck

Merck & Company quickly lost about 4% of its market value in the pre-market trading on July 30, to re-test its major $120 to $122.50 technical support area. This was an immediate response to the drug giant's updating its own earnings forecast for the rest of the year. Merck CEOs adjusted their guidance to a range between $7.94 and $8.04, from previous estimates of $8.53 to $8.65 per share. Yet, the main reasons for lower forecasts were seemingly boiling down to one-time charges from an acquisition of eye-focused drug developer EyeBio, which cost nearly $1.3 billion, or $0.51 per share. Consensus expectations at $8.16 per share included this factor into consideration, and so nothing extraordinary happened from our point of view.

Meanwhile, Merck business continued to win. Keytruda medicine for cancer immunotherapy, which used to make the largest revenue contribution, jumped above $30 billion annually, hitting $7.3 billion in the quarter, up 16% YoY vs expected numbers of slightly above $7.1 billion. Besides, Merck launched a drug Winrevair for a rare lung condition called pulmonary arterial hypertension. Many feel Winrevair may have a blockbuster potential, as it already gave $70 million in sales, which is higher than the most bullish estimates. Sales of Gardasil, a vaccine widely used in the prevention of human papillomavirus, were also growing. The company's boss Robert Davis separately emphasized Merck's participation in vaccine programs, including the US FDA regulatory approval and CDC's (The Centers for Disease Control and Prevention) recommendation for a pneumococcal vaccine, and positive results from a trial of an investigational RSV (respiratory syncytial virus) preventative monoclonal antibody for infants.

From a pure financial point of view, the company raised its full-year 2024 sales projections to a slightly higher range of $63.4 billion to $64.4 billion. Merck's sales globally rose by 7% to $16.1 billion, above average expectations of $15.8 billion, sales added 11% if the Wall Street crowd takes into account adjusting for currency exchange impacts. On Tuesday Merck also revealed $5.5 billion of Q2 profit, or $2.14 per share. Excluding this one-time stuff, the last quarter brought $2.28 per share vs consensus expectations of $2.15. The outlook looks so strong, that any current price discount is just an opportunity to add more to investors' stake in Merck. Merck is surely a top pick, even though not a buy for immediate use, better to postpone for a week or so until the dust settles.

4445
Rafael Quintana Martinez
Money Manager de alto rendimiento, con una sólida formación académica, profesional y de campo. Más de 9 años de experiencia especializada en el comercio de mercados financieros internacionales. La devoción, la fiabilidad, la responsabilidad y la ética impulsan mi vida. Actualmente me desempeño como Analista Senior para Metadoro. https://metadoro.com/es https://mx.investing.com/members/contributors/235587671/ https://es.tradingview.com/chart/EURUSD/rE9gVips/
APE Stuck in a Flat Range

ApeCoin (APE) is experiencing a rise of 4.7% this week, reaching $0.796. This increase has allowed the token to break through the resistance of the downside trend that has persisted since March 13. However, the current price movements are primarily within a flat range, indicating that APE is struggling to gain further upward momentum.

A potential catalyst for future growth is the ApeCoin DAO's proposal to create a Bored Ape-themed hotel in Bangkok, which is garnering significant support from the community. If the project proceeds, it could positively impact the token's value. With this development, APE has the potential to test the resistance level at $1.000.

4487
146

Join our community

Share your professional and amateur observations, exchange experiences, anticipate developments

Category
All
Stocks
Crypto
Etf
Commodities
Indices
Currencies
Energies
Metals
Instruments
Author
All
Metadoro
Contributors